Oscar Health, Inc.
Oscar Health, Inc. OSCR Peers
See (OSCR) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Healthcare Plans Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| OSCR | $16.91 | +0.51% | 3.70B | 169.05 | $0.10 | N/A |
| UNH | $311.22 | -17.83% | 282.32B | 13.03 | $23.89 | +2.22% |
| ANTM | $482.58 | +2.71% | 114.59B | 18.99 | $25.41 | +1.59% |
| ELV | $375.26 | -9.94% | 84.78B | 14.60 | $25.71 | +1.59% |
| CI | $301.93 | -4.38% | 80.66B | 16.84 | $17.93 | +1.82% |
| CVS | $60.50 | -6.65% | 76.53B | 14.44 | $4.19 | +4.16% |
| CNC | $58.96 | -6.23% | 29.34B | 8.70 | $6.78 | N/A |
| HUM | $228.75 | -9.53% | 27.61B | 16.14 | $14.17 | +1.41% |
| MOH | $310.38 | -5.28% | 16.82B | 14.99 | $20.70 | N/A |
| ALHC | $14.05 | -5.83% | 2.78B | -29.89 | -$0.47 | N/A |
Stock Comparison
OSCR vs UNH Comparison
OSCR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSCR stands at 3.70B. In comparison, UNH has a market cap of 282.32B. Regarding current trading prices, OSCR is priced at $16.91, while UNH trades at $311.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSCR currently has a P/E ratio of 169.05, whereas UNH's P/E ratio is 13.03. In terms of profitability, OSCR's ROE is +0.02%, compared to UNH's ROE of +0.32%. Regarding short-term risk, OSCR is less volatile compared to UNH. This indicates potentially lower risk in terms of short-term price fluctuations for OSCR.
OSCR vs ANTM Comparison
OSCR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSCR stands at 3.70B. In comparison, ANTM has a market cap of 114.59B. Regarding current trading prices, OSCR is priced at $16.91, while ANTM trades at $482.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSCR currently has a P/E ratio of 169.05, whereas ANTM's P/E ratio is 18.99. In terms of profitability, OSCR's ROE is +0.02%, compared to ANTM's ROE of +0.14%. Regarding short-term risk, OSCR is more volatile compared to ANTM. This indicates potentially higher risk in terms of short-term price fluctuations for OSCR.
OSCR vs ELV Comparison
OSCR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSCR stands at 3.70B. In comparison, ELV has a market cap of 84.78B. Regarding current trading prices, OSCR is priced at $16.91, while ELV trades at $375.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSCR currently has a P/E ratio of 169.05, whereas ELV's P/E ratio is 14.60. In terms of profitability, OSCR's ROE is +0.02%, compared to ELV's ROE of +0.14%. Regarding short-term risk, OSCR is less volatile compared to ELV. This indicates potentially lower risk in terms of short-term price fluctuations for OSCR.
OSCR vs CI Comparison
OSCR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSCR stands at 3.70B. In comparison, CI has a market cap of 80.66B. Regarding current trading prices, OSCR is priced at $16.91, while CI trades at $301.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSCR currently has a P/E ratio of 169.05, whereas CI's P/E ratio is 16.84. In terms of profitability, OSCR's ROE is +0.02%, compared to CI's ROE of +0.12%. Regarding short-term risk, OSCR is more volatile compared to CI. This indicates potentially higher risk in terms of short-term price fluctuations for OSCR.
OSCR vs CVS Comparison
OSCR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSCR stands at 3.70B. In comparison, CVS has a market cap of 76.53B. Regarding current trading prices, OSCR is priced at $16.91, while CVS trades at $60.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSCR currently has a P/E ratio of 169.05, whereas CVS's P/E ratio is 14.44. In terms of profitability, OSCR's ROE is +0.02%, compared to CVS's ROE of +0.07%. Regarding short-term risk, OSCR is more volatile compared to CVS. This indicates potentially higher risk in terms of short-term price fluctuations for OSCR.
OSCR vs CNC Comparison
OSCR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSCR stands at 3.70B. In comparison, CNC has a market cap of 29.34B. Regarding current trading prices, OSCR is priced at $16.91, while CNC trades at $58.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSCR currently has a P/E ratio of 169.05, whereas CNC's P/E ratio is 8.70. In terms of profitability, OSCR's ROE is +0.02%, compared to CNC's ROE of +0.13%. Regarding short-term risk, OSCR is more volatile compared to CNC. This indicates potentially higher risk in terms of short-term price fluctuations for OSCR.
OSCR vs HUM Comparison
OSCR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSCR stands at 3.70B. In comparison, HUM has a market cap of 27.61B. Regarding current trading prices, OSCR is priced at $16.91, while HUM trades at $228.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSCR currently has a P/E ratio of 169.05, whereas HUM's P/E ratio is 16.14. In terms of profitability, OSCR's ROE is +0.02%, compared to HUM's ROE of +0.10%. Regarding short-term risk, OSCR is more volatile compared to HUM. This indicates potentially higher risk in terms of short-term price fluctuations for OSCR.
OSCR vs MOH Comparison
OSCR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSCR stands at 3.70B. In comparison, MOH has a market cap of 16.82B. Regarding current trading prices, OSCR is priced at $16.91, while MOH trades at $310.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSCR currently has a P/E ratio of 169.05, whereas MOH's P/E ratio is 14.99. In terms of profitability, OSCR's ROE is +0.02%, compared to MOH's ROE of +0.26%. Regarding short-term risk, OSCR is more volatile compared to MOH. This indicates potentially higher risk in terms of short-term price fluctuations for OSCR.
OSCR vs ALHC Comparison
OSCR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSCR stands at 3.70B. In comparison, ALHC has a market cap of 2.78B. Regarding current trading prices, OSCR is priced at $16.91, while ALHC trades at $14.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSCR currently has a P/E ratio of 169.05, whereas ALHC's P/E ratio is -29.89. In terms of profitability, OSCR's ROE is +0.02%, compared to ALHC's ROE of -0.81%. Regarding short-term risk, OSCR is less volatile compared to ALHC. This indicates potentially lower risk in terms of short-term price fluctuations for OSCR.
OSCR vs CLOV Comparison
OSCR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSCR stands at 3.70B. In comparison, CLOV has a market cap of 1.73B. Regarding current trading prices, OSCR is priced at $16.91, while CLOV trades at $3.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSCR currently has a P/E ratio of 169.05, whereas CLOV's P/E ratio is -37.78. In terms of profitability, OSCR's ROE is +0.02%, compared to CLOV's ROE of -0.13%. Regarding short-term risk, OSCR is more volatile compared to CLOV. This indicates potentially higher risk in terms of short-term price fluctuations for OSCR.
OSCR vs BHG Comparison
OSCR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSCR stands at 3.70B. In comparison, BHG has a market cap of 130.51M. Regarding current trading prices, OSCR is priced at $16.91, while BHG trades at $16.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSCR currently has a P/E ratio of 169.05, whereas BHG's P/E ratio is -0.12. In terms of profitability, OSCR's ROE is +0.02%, compared to BHG's ROE of +3.25%. Regarding short-term risk, OSCR is less volatile compared to BHG. This indicates potentially lower risk in terms of short-term price fluctuations for OSCR.
OSCR vs BMGL Comparison
OSCR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSCR stands at 3.70B. In comparison, BMGL has a market cap of 84.54M. Regarding current trading prices, OSCR is priced at $16.91, while BMGL trades at $4.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSCR currently has a P/E ratio of 169.05, whereas BMGL's P/E ratio is 50.00. In terms of profitability, OSCR's ROE is +0.02%, compared to BMGL's ROE of N/A. Regarding short-term risk, OSCR is less volatile compared to BMGL. This indicates potentially lower risk in terms of short-term price fluctuations for OSCR.
OSCR vs MRAI Comparison
OSCR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSCR stands at 3.70B. In comparison, MRAI has a market cap of 19.66M. Regarding current trading prices, OSCR is priced at $16.91, while MRAI trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSCR currently has a P/E ratio of 169.05, whereas MRAI's P/E ratio is -0.45. In terms of profitability, OSCR's ROE is +0.02%, compared to MRAI's ROE of +0.93%. Regarding short-term risk, OSCR is less volatile compared to MRAI. This indicates potentially lower risk in terms of short-term price fluctuations for OSCR.
OSCR vs NIVF Comparison
OSCR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSCR stands at 3.70B. In comparison, NIVF has a market cap of 2.44M. Regarding current trading prices, OSCR is priced at $16.91, while NIVF trades at $3.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSCR currently has a P/E ratio of 169.05, whereas NIVF's P/E ratio is -0.01. In terms of profitability, OSCR's ROE is +0.02%, compared to NIVF's ROE of +0.03%. Regarding short-term risk, OSCR is less volatile compared to NIVF. This indicates potentially lower risk in terms of short-term price fluctuations for OSCR.
OSCR vs IVF Comparison
OSCR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSCR stands at 3.70B. In comparison, IVF has a market cap of 2.11M. Regarding current trading prices, OSCR is priced at $16.91, while IVF trades at $1.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSCR currently has a P/E ratio of 169.05, whereas IVF's P/E ratio is -0.07. In terms of profitability, OSCR's ROE is +0.02%, compared to IVF's ROE of N/A. Regarding short-term risk, OSCR is less volatile compared to IVF. This indicates potentially lower risk in terms of short-term price fluctuations for OSCR.